FINE-HEART Pooled Analysis
Dr. Pabon discusses new data from ACC 2025 showing that finerenone significantly lowers new-onset AF risk across the cardio-kidney-metabolic spectrum.
Media formats available
Completing the pre-test is required to access this content.
Pre-Survey
Completing the pre-survey is required to access this content.